Reported Earlier, Moderna's mFLUSIVA Wins FDA Approval As First mRNA-Based Flu Vaccine For Adults 50 And Older
Share
Why It Matters
Moderna just got permission to sell a new flu shot made with mRNA technology—the same tech used in their COVID vaccine. This shows their science works for more than just COVID, which is good news for the company's future.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.